Is SVA a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

469 people get SVA articles and Market Currents by email alert.

Get email alerts on SVA »

FOCUS | PRO | RELATED | TRANSCRIPTS | NEWS & PR

Sinovac: The Diamond In The Rough
Sandor Feher • Mon, Oct 24, 2011
Sinovac Announces Success for EV71 Vaccine
ChinaBio Today • Wed, May 25, 2011 • 2 Comments
Sinovac Ventures Into Realm of Bacterial Vaccines
ChinaBio Today • Tue, Feb 1, 2011
Sinovac Adds EV71 Vaccine to Steadily Increasing Offerings
ChinaBio Today • Wed, Dec 29, 2010
Sinovac Slashes 2010 Revenue Guidance by One-Third
ChinaBio Today • Mon, Oct 25, 2010
Sinovac After 2009's Flu Scare
ChinaBio Today • Tue, Aug 17, 2010 • 2 Comments
Sinovac Wins Order for China’s National Immunization Program
ChinaBio Today • Tue, Jun 1, 2010
Sinovac Hopes to Begin Mumps Vaccine Trial
ChinaBio Today • Thu, May 6, 2010
Sinovac Provides Color to Strong 2009 Results
ChinaBio Today • Thu, Apr 8, 2010
Sinovac Finds India Partner for H1N1 Vaccine
ChinaBio Today • Sun, Mar 21, 2010
Sinovac Closes Deal on New Manufacturing Facility
ChinaBio Today • Tue, Feb 16, 2010
Sinovac's Secondary Offering Will Help Fund Acquisitions
ChinaBio Today • Thu, Jan 28, 2010
Sinovac Issues 2009 Guidance, Announces Secondary Stock Issue
ChinaBio Today • Thu, Jan 21, 2010
Sinovac Files to Begin Vaccine Trial for Hand, Food and Mouth Disease
ChinaBio Today • Tue, Dec 29, 2009
Sinovac Named Among China's Top 10 Most Competitive Companies
ChinaBio Today • Tue, Dec 22, 2009 • 1 Comment
Sinovac Adds Vaccine Capacity by Forming JV
ChinaBio Today • Thu, Nov 26, 2009 • 1 Comment
Sinovac’s Q3 Soars
ChinaBio Today • Tue, Nov 17, 2009 • 3 Comments
Sinovac Set to Move Listing to NASDAQ
ChinaBio Today • Wed, Nov 4, 2009 • 6 Comments
Sinovac on Track to See Sizable Revenue from Flu Vaccines
ChinaBio Today • Wed, Oct 28, 2009
Sinovac Wins Approval for Swine Flu Vaccine in Mexico
ChinaBio Today • Fri, Oct 23, 2009

To learn more about Seeking Alpha Pro, click here.

China Biotech In Review: Valeant Pharma Gains Sales Foothold In China With Bausch & Lomb Buy
ChinaBio Today • Sun, Jun 2
Biotechs Ramping Up On China's Avian Flu Outbreak
David Zanoni • Mon, Apr 8 • 12 Comments
China Biotech In Review: Simcere Receives $503 Million Privatization Offer
ChinaBio Today • Sun, Mar 17
5 Biotech Winners From Last Week With High Short Ratios
Heisenberg Principle • Mon, Dec 24, 2012
3 Vaccine Companies With Upcoming Catalysts
Markus Aarnio • Sun, Sep 9, 2012 • 6 Comments
Micro Cap Biotech Stocks Being Accumulated By The World's Largest Money Managers
GuruFundPicks • Wed, Jul 11, 2012 • 9 Comments
Top Micro Cap Biotech Stocks Being Accumulated By Legendary Fund Managers
GuruFundPicks • Tue, Apr 17, 2012 • 12 Comments
16 Biotech Stocks Sold Off By Hedge Funds
Kapitall • Mon, Apr 2, 2012 • 1 Comment
3 Biotech Stocks With Encouraging Receivable Trends
Kapitall • Thu, Feb 23, 2012
Interferon's Role In Flu Control Shouldn't Be Underestimated
Jessica King Holden • Wed, Jan 11, 2012 • 4 Comments
20 Biotech Stocks That Hedge Funds Are Selling
Kapitall • Sun, Dec 11, 2011 • 1 Comment
20 Healthcare Stocks With Positive Receivables Trends
Kapitall • Wed, Nov 16, 2011 • 1 Comment
China Biotech Week In Review: WuXi PharmaTech Forms Venture Fund
ChinaBio Today • Mon, Nov 14, 2011
China Biotech Week In Review: Sinovac Biotech Receives Some Good News
ChinaBio Today • Sun, Oct 16, 2011 • 2 Comments
China Biotech Week In Review: Sinovac Begins Foray Into Animal Health Vaccines
ChinaBio Today • Sun, Oct 2, 2011
20 Healthcare Stocks With Positive Accounts Receivable Trends
Kapitall • Tue, Sep 13, 2011
China Products Group: 3 Buy Ideas and 1 Sell Idea From High Alpha Funds
GuruFundPicks • Wed, Jun 29, 2011 • 2 Comments
China Biotech Week in Review: Deals and Transactions, Trials and Approvals
ChinaBio Today • Sun, May 29, 2011
China Biotech Q1 Earnings Review: Healthy Revenue Increases, Smaller Profit Growth
ChinaBio Today • Tue, May 24, 2011 • 1 Comment
Extreme Pessimism: 15 Downtrend Stocks Being Dumped by Institutional Investors
Kapitall • Mon, May 9, 2011 • 7 Comments

Sinovac Biotech's CEO Discusses Q1 2013 Results - Earnings Call Transcript
Tue, May 28
Sinovac Biotech's CEO Discusses F4Q2012 Results - Earnings Call Transcript
Thu, Apr 18
Sinovac Biotech's CEO Discusses Q3 2012 Results - Earnings Call Transcript
Fri, Nov 16, 2012
Sinovac Biotech's CEO Discusses Q2 2012 Results - Earnings Call Transcript
Wed, Aug 15, 2012
Sinovac Biotech Ltd. Q4 2009 Earnings Call Transcript
Tue, Apr 6, 2010
Sinovac Biotech Limited Q2 2009 Earnings Call Transcript
Wed, Aug 19, 2009 • 1 Comment

Sinovac Appoints New Chief Financial Officer

PR Newswire (May 31, 2013)
Sinovac Files New Drug Application for EV71 Vaccine and Receives Filing Acceptance from Beijing Drug Administration

PR Newswire (May 30, 2013)
Sinovac Reports Unaudited First Quarter 2013 Financial Results

PR Newswire (May 28, 2013)
Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines

PR Newswire (May 24, 2013)
Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results

PR Newswire (May 17, 2013)
Sinovac Appoints Ernst & Young Hua Ming Llp China as External Auditor

PR Newswire (May 15, 2013)
Sinovac Presents at the UBS Global Healthcare Conference in May 2013

PR Newswire (May 14, 2013)
Sinovac Files Annual Report on Form 20-F

PR Newswire (Apr 30, 2013)
Sinovac Reports Unaudited Fourth Quarter and Full Year 2012 Financial Results

PR Newswire (Apr 18, 2013)
Sinovac EV71 Vaccine Phase III Top-Line Results Presented at 13th Annual World Vaccine Congress & Expo

PR Newswire (Apr 18, 2013)
Sinovac Receives Commercial Approval in Mexico for Seasonal Flu Vaccine

PR Newswire (Apr 18, 2013)
Movers & Shakers: Friday’s movers: Network-equipment shares hammered

at MarketWatch.com (Apr 5, 2013)
Sinovac Schedules Conference Call and Webcast for Fourth Quarter and Full Year Unaudited Financial Results

PR Newswire (Apr 2, 2013)
Sinovac Reports Preliminary Top-Line Results from Phase III Clinical Trial for EV71 Vaccine Candidate Against Hand, Foot and Mouth Disease

PR Newswire (Mar 14, 2013)
Sinovac Reports Unaudited Third Quarter 2012 Financial Results

PR Newswire (Nov 15, 2012)
Sinovac to Host Conference Call to Report Third Quarter 2012 Unaudited Financial Results

PR Newswire (Oct 29, 2012)
Sinovac Awarded Tenders in Beijing and Shanghai to Supply Inactivated Hepatitis A Vaccine Healive® Under Expanded Immunization Program

PR Newswire (Sep 25, 2012)
Sinovac Biotech Receives GMP Certification for Mumps Vaccine Production Facility

PR Newswire (Sep 18, 2012)
Sinovac Receives Beijing CDC Tender Award to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens

PR Newswire (Sep 10, 2012)
Sinovac Holds 2012 Annual General Meeting of Shareholders

PR Newswire (Aug 23, 2012)

SVA vs. ETF Alternatives

Company Description

Currently, there's no company description for SVA.

Sector: Healthcare

Industry: Biotechnology

Country: China

All
| Earnings
| Dividends
| M&A
| On the move

Friday, May 31, 5:23 PM Sinovac Biotech (SVA) says that its current CFO, Mr. Danny Chung, has resigned for family reasons. Ms. Nan Wang has been appointed as his replacement, effective June 1. Ms. Wang oversaw SVA's business development, strategic management and investment. She was instrumental in leading the Company's successful public offering in early 2010. Comment! [Global & FX, Healthcare]
Thursday, May 30, 10:59 AM Sinovac Biotech (SVA +3.9%) says a new drug application for its proprietary EV71 vaccine has been filed and accepted by the Beijing Drug Administration. SVA completed the Phase III clinical trials for the vaccine in March, and top-line data showed approximately a 95% efficacy rate against HFMD caused by enterovirus 71. The Administration plans to conduct an on-site inspection and will submit its opinion to China's Food and Drug Administration for further review and evaluation. Comment! [Healthcare, Global & FX, On the Move]
Tuesday, May 28, 12:45 PM Midday top 10 gainers: VRTB +23%. PIP +21%. LSE +20%. CSIQ +19%. HSOL +18%. HYGS +17%. BLDP +16%. OBCI +13%. SVA +14%. UACL +12%.
Midday top 10 Losers: ENOC -19%. FSGI -13%. RSOL -12%. OXBT -12%. HGSH -11%. BDL -10%. CLNT -10%. VIPS -9%. RPI -9%. ZIOP -9%. Comment! [On the Move]
Tuesday, May 28, 7:17 AM Sinovac Biotech (SVA): Q1 EPS of -$0.04 beats by $0.06. Revenue of $10.1M misses by $0.19M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Thursday, April 18, 9:30 AM Notables from Sinovac's (SVA) financial results: 1) stripping out 2011 Panflu sales related to the government's stockpiling program, Q4 and FY12 sales rose 166.9% and 38.6% respectively; 2) success in Phase III clinicals for EV71 vaccine made 2012 a "transformative year" for the company; 3) growth in sales of core products (Healive, Bilive, Anflu) "very" pleasing. SVA also says Mexican regulators have approved the commercialization of the seasonal flu vaccine. Shares +1.2% premarket. Comment! [Healthcare]
Thursday, April 18, 8:26 AM Sinovac Biotech (SVA): FQ4 EPS of -$0.10 misses by $0.10. Revenue of $19M beats by $14.2M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Monday, April 15, 9:15 AM Premarket gainers: S +16%. SVA +13%. BCRX +10%. LIFE +8%. NFP +7%. MGT +7%. TMO +6%. THRX +5%. NVAX +5%.
Losers: AAU -15%. MTL -10%. AUQ -11%. HMY -9%. NGD -8%. CEF -8%. SLW -8%. SAND -9%. KGC -7%. AUY -7%. GOLD -7%. MUX -7%. DSCO -7%. IAG -6%. SVM -6%. GG -6%. PAAS -6%. EGO -6%. AU -5%. CDE -5%. Comment! [On the Move]
Monday, April 15, 8:39 AM Biotechs rise in early trading as the death toll from the new avian flu strain jumps to 13. Sinovac (SVA) is preparing immunizations and can manufacture 30-40M doses annually, according to Bloomberg. Meanwhile, investors continue to bet BioCryst's (BCRX) peramavir could have a role to play. Premarket moves: SVA +9.6%, BCRX +7.4%, NVAX +5%. Comment! [On the Move, Healthcare]
Friday, April 5, 11:09 AM BioCryst Pharmaceuticals (BCRX +17.4%) pops on news that six deaths in China have been linked to a new strain of avian flu. BCRX is developing peramivir, which has been shown in preclinical studies to help treat highly virulent strains of influenza - including the bird flu strain known as the H5N1 virus. Other drug stocks moving higher on the news: Pure Bioscience (PURE +15.6%), Hemispherx BioPharma (HEB +13.3%), Sinovac Biotech (SVA +7.8%), and Novavax (NVAX +1.1%). Comment! [Healthcare, On the Move]
Thursday, March 14, 7:52 AM Sinovac's (SVA) Enterovirus 71 (EV71) vaccine for hand, foot & mouth disease prevented the infection of infants aged 6-35 months in a Phase III trial, showing a 95.4% efficacy rate and meeting the primary endpoint of the study. (PR) 1 Comment [Healthcare]
Monday, December 24, 2012, 11:15 AM Midday top 10 gainers: ATV +34%. CT +18%. ALIM +12%. CLSN +12%. EJ +11%. EDAP +11%. GSS +11%. RGLS +10%. AVEO +10%. EGLE +10%.
Top 10 Losers: MHH -30%. TLAB -27%. ALXA -14%. XRTX -12%. AMPL -11%. CIG -10%. SVA -9%. ISS -9%. MITL -8%. RPTP -8%. 1 Comment [On the Move]
Thursday, November 15, 2012, 6:31 AM Sinovac Biotech (SVA): Q3 EPS of -$0.06 misses by $0.03. Revenue of $14.3M (-7% Y/Y) beats by $2M. (PR) Comment! [Earnings, Healthcare]
Tuesday, September 25, 2012, 12:45 PM Midday top 10 gainers: PPHM +42%. ECBE +35%. TGAL +21%. GENE +20%. MTN +12%. SVA +12%. PFSW +12%. UCFC +11%. NTIC +11%. SVN +11%.
Top 10 Losers: GEVO -32%. MACK -19%. OMEX -19%. DAEG -17%. SWSH -16%. DLGC -12%. KEG -12%. IOT -11%. RSH -10%. CGNX -10%. Comment!
Thursday, October 13, 2011, 11:32 AM Sinovac Biotech (SVA +6.7%) is trading higher after saying it's been selected by the Beijing Centers for Disease Control and Prevention as one of four manufacturers to supply a seasonal influenza vaccine to Beijing. Comment! [Healthcare, Global & FX, On the Move]
Tuesday, April 6, 2010, 9:00 AM Premarket gainers: CPBY +29%. AVNR +11%. PUDA +5%.
Losers: TNK -7%. MEE -7%. RDEA -7%. UNIS -6%. NBG -5%. IRE -4%. SVA -4%. STD -4%. VOD -4%. CA -4%. PMI -4%. Comment!
Thursday, January 21, 2010, 9:00 AM Premarket gainers: IMMU +12%. STX +11%. CYTR +9%. EBAY +9%. PLXS +8%. FCS +7%. FITB +6%. FFIV +4%. KEY +4%. SNE +4%.
Losers: ISPH -15%. SVA -8%. GRMN -7%. BCS -4%. RTP -4%. RBS -4%. Comment!

Ryan Mallory
Fuinhaz Setups for April 18 2013 | $ASML $GOLD $MU $SNDK $SVA $TZOO $VOD $ZNGA | SharePlanner http://bit.ly/13ku3CQ
Apr 18, 9:07 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Ryan Mallory
Fuinhaz Setups for April 16 2013 | $AMGN $BBRY $FSC $GOLD $SHPG $SONS $SSRI $SVA $ZNGA | http://bit.ly/12iTo1d
Apr 16, 8:56 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Ryan Mallory
Fuinhaz Setups for April 8 2013 | $AMRN $BCRX $FSLR $GLUU $PERI $RIGL $SRPT $SVA $ZNGA | http://bit.ly/10MTLwT
Apr 8, 9:11 AM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Rocket Robin
$SVA +10% today on birds flu talks. Is rally over yet ? (2.36 to 2.63)
12/21/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Rocket Robin
Uh oooh. Lot of posts regarding birds flu. Time to load on $SVA ?
12/21/11
Reply (2)

• !Report Abuse
View all 2 replies
Rocket Robin: 2.36 to 2.44 just now
12/21/11
• !Report Abuse
sapaburu: Or NVAX
12/21/11
• !Report Abuse
Add a reply...

140 characters

Michael Bryant
Flu vaccine maker Sinovac Biotech (SVA) surged on 26% profit rise. It has four upcoming conferences. http://yhoo.it/nbwWWG
8/30/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

MagicDiligence
Small-cap Chinese has gotten incredibly cheap. Investors hate these stocks right now. $CSKI.PK $UTRA.PK $CEAI.PK $LIWA $SVA
5/11/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

MagicDiligence
New MFI Stock Sinvac Biotech $SVA China vaccines. Another beneficiary of H1N1, but good metrics. Adding to research queue if it sticks.
4/9/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

FocalPoint Analytics
Sadly, SVA announced yet another stock offering further diluting the stock.
1/21/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

fran grady
China had good balance of payment. Asia up in general. New EV17 Hoof&Mouth vaccine in the works..Long on SVA
1/11/10
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

Rocket Robin
Uh oooh. Lot of posts regarding birds flu. Time to load on $SVA ?
12/21/11
Reply (2)

• !Report Abuse
View all 2 replies
Rocket Robin: 2.36 to 2.44 just now
12/21/11
• !Report Abuse
sapaburu: Or NVAX
12/21/11
• !Report Abuse
Add a reply...

140 characters

SVA Sinovac Biotech, Ltd.

SVA

Sinovac Biotech, Ltd.